BETonMACE obviously....but have the trials for BETonRENAL and Fabry's started already?  

Resverlogix has initiated clinical trials of apabetalone in three indications: – Cardiovascular Disease (BETonMACE Trial) – Chronic Kidney Disease (BETonRENAL Trial) – Fabry’s Disease 

Safe Harbour provisions cover forward looking statements....not about what has already happened.  A company can't say "We had $100 million in revevenue for the past quarter" and use safe harbor if its not true.  "Has initiated" in the past tense of the verb....meaning its already happened.